The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Cefotaxime 1 g powder for solution for injection/infusion

Noridem Enterprises LimitedPA1122/019/002

Main Information

Trade NameCefotaxime 1 g powder for solution for injection/infusion
Active SubstancesCefotaxime
Dosage FormPowder for solution for injection/infusion
Licence HolderNoridem Enterprises Limited
Licence NumberPA1122/019/002

Group Information

ATC CodeJ01DD Third-generation cephalosporins
J01DD01 cefotaxime


License statusAuthorised
Licence Issued26/06/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back